APA (7th ed.) Citation

H, K., K, N., A, M., H, K., S, M., Y, N., . . . K, M. (2025). Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study). Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 28(1), 51. https://doi.org/10.1007/s10120-024-01555-w

Chicago Style (17th ed.) Citation

H, Kawakami, et al. "Real-world Effectiveness and Safety of Trastuzumab-deruxtecan in Japanese Patients with HER2-positive Advanced Gastric Cancer (EN-DEAVOR Study)." Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 28, no. 1 (2025): 51. https://doi.org/10.1007/s10120-024-01555-w.

MLA (9th ed.) Citation

H, Kawakami, et al. "Real-world Effectiveness and Safety of Trastuzumab-deruxtecan in Japanese Patients with HER2-positive Advanced Gastric Cancer (EN-DEAVOR Study)." Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol. 28, no. 1, 2025, p. 51, https://doi.org/10.1007/s10120-024-01555-w.